MTOR and acute lymphoblastic leukemia: IKAROS binding at the MTOR promoter was determined by a quantitative chromatin immunoprecipitation (qChIP) assay of primary B-ALL cells (Fig. 1c), and B-ALL cell lines (Fig. S2).